# Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases

> **NCT02145039** · NA · TERMINATED · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 2 (actual)

## Conditions studied

- Acute Leukemias
- Burkitt's Lymphoma
- Chronic Myelogenous Leukemia

## Interventions

- **DRUG:** Fludarabine
- **DRUG:** Cyclophosphamide
- **RADIATION:** Total Body Irradiation
- **BIOLOGICAL:** Haploidentical stem cell transplant

## Key facts

- **NCT ID:** NCT02145039
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-10
- **Primary completion:** 2018-01
- **Final completion:** 2019-01
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Replaced by another study.
- **Last updated:** 2019-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02145039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02145039, "Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT02145039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*